Pomerantz LLP investigates PetMed Express for securities fraud.

jueves, 8 de enero de 2026, 10:12 am ET1 min de lectura
PETS--

• PetMed Express, Inc. (NASDAQ: PETS) investigated for securities fraud. • Delayed earnings release and conference call in June 2025. • Stock price fell 11.22% to $3.72 per share. • Additional time needed for year-end audit process. • Filing of annual report delayed until July 31, 2025. • Investors advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios